Home » Topics » Disease categories and therapies » Urology

Urology
RSS

IC-351 effective and safe as once-daily or on-demand therapy for ED

Oct. 6, 2000

Selective V2 receptor agonists from AHP and their use described in patents

Sep. 25, 2000

Recordati identifies potent and selective alpha1D-adrenoceptor antagonists based on BMY-7378

Sep. 21, 2000

Enrollment completed in pivotal phase III trial of Chondrogel

Sep. 21, 2000

Sanofi-Synthelabo discloses synthesis and use of new alpha-azacyclomethylquinolines

Sep. 19, 2000

Preclinical results in guinea pigs suggest novel mechanism of action for TAK-637

Sep. 18, 2000

Update on U.S. status of Zonagen's sexual dysfunction products

Sep. 15, 2000

Cystistat approved for expanded indications in Europe

Sep. 14, 2000

Renal I/R injury prevented by VAS-971 therapy in canine model

Sep. 14, 2000

Arch scientists discover new peptides with mitogenic properties

Sep. 12, 2000

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...